Association Between Systolic Ejection Time and Outcomes in Heart Failure by Ejection Fraction
- 21 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 22 (7) , 1174-1182
Abstract
Aims Worsening heart failure (HF) is associated with shorter left ventricular systolic ejection time (SET), but there are limited data describing the relationship between SET and clinical outcomes. Thus, the objective was to describe the association between SET and clinical outcomes in an ambulatory HF population irrespective of ejection fraction (EF). Methods and results We identified ambulatory patients with HF with reduced EF (HFrEF) and HF with preserved EF (HFpEF) who had an outpatient transthoracic echocardiogram performed between August 2008 and July 2010 at a tertiary referral centre. Multivariable logistic regression was used to evaluate the association between SET and 1‐year outcomes. A total of 545 HF patients (171 HFrEF, 374 HFpEF) met eligibility criteria. Compared with HFpEF, HFrEF patients were younger [median age 60 years (25th–75th percentiles 50–69) vs. 64 years (25th–75th percentiles 53–74], with fewer females (30% vs. 56%) and a similar percentage of African Americans (36% vs. 35%). Median (25th–75th percentiles) EF with HFrEF was 30% (25–35%) and with HFpEF was 54% (48–58%). Median SET was shorter (280 ms vs. 315 ms, P < 0.001), median pre‐ejection period was longer (114 ms vs. 89 ms, P < 0.001), and median relaxation time was shorter (78.7 ms vs. 93.3 ms, P < 0.001) among patients with HFrEF vs. HFpEF. Death or HF hospitalization occurred in 26.9% (n = 46) HFrEF and 11.8% (n = 44) HFpEF patients. After adjustment, longer SET was associated with lower odds of the composite of death or HF hospitalization at 1 year among HFrEF but not HFpEF patients. Conclusion Longer SET is independently associated with improved outcomes among HFrEF patients but not HFpEF patients, supporting a potential role for normalizing SET as a therapeutic strategy with systolic dysfunction.Keywords
Funding Information
- NIH (T32-HL007101)
- NIH (5T32HL069749)
- National Institutes of Health (T32‐HL007101)
- National Institutes of Health (5T32HL069749)
This publication has 27 references indexed in Scilit:
- Established and Novel Clinical Applications of Diastolic Function Assessment by EchocardiographyCirculation: Cardiovascular Imaging, 2011
- Ivabradine in heart failure—no paradigm SHIFT…yetThe Lancet, 2010
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialThe Lancet, 2010
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Left Ventricular Ejection Time on Echocardiography Predicts Long-Term Mortality in Light Chain AmyloidosisJournal of the American Society of Echocardiography, 2009
- Diastolic stress echocardiography: A novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiographyJournal of the American Society of Echocardiography, 2005
- American Society of Echocardiography recommendations for use of echocardiography in clinical trialsJournal of the American Society of Echocardiography, 2004
- Prognostic value of the Tei index combining systolic and diastolic myocardial performance in patients with acute myocardial infarction treated by successful primary angioplastyHeart and Vessels, 2004
- Systolic Time Intervals in Heart Failure in ManCirculation, 1968
- Relationships between left ventricular ejection time, stroke volume, and heart rate in normal individuals and patients with cardiovascular diseaseAmerican Heart Journal, 1961